324365004: Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampule (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

465340012 Co-trimoxazole 480mg/5mL intravenous infusion en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

1475635016 Co-trimoxazole 96mg/mL infusion concentrate 5mL ampoule en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

1476593011 Co-trimoxazole 96mg/mL infusion concentrate 5mL ampule en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

2463716011 Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampule (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

2469016013 Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampoule en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

2469494019 Co-trimoxazole 16mg/80mg/mL infusion concentrate 5mL ampule en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

2475008011 Trimethoprim 80mg/Sulfamethoxazole 400mg infusion concentrate 5mL ampoule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2475218014 Trimethoprim 80mg/Sulfamethoxazole 400mg infusion concentrate 5mL ampule en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

322441000077119 cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	Is a	Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	cotrimoxazolo	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Urinary anti-infective	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Trimethoprim (substance)	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Sulfamethoxazole (substance)	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bactericide	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	Has manufactured dose form	injection	false	Inferred relationship	Some
cotrimoxazole 16 mg/80 mg/mL, ampoule de 5 mL de concentré pour perfusion	Has manufactured dose form	Infusion concentrate	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

Description inactivation indicator reference set